Mabwell (Shanghai) Bioscience Co (HKSE:02493) NonCurrent Deferred Liabilities: HK$0.0 Mil (As of Mar. 2026)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Mabwell (Shanghai) Bioscience Co Ltd HKSE:02493

43 GF Score

Price HK$22.50

GF Value HK$95.37

Valuation Possible Value Trap

5 Warning Signs

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

What is Mabwell (Shanghai) Bioscience Co NonCurrent Deferred Liabilities?

Mabwell (Shanghai) Bioscience Co HKSE:02493 -1.06% 43 NonCurrent Deferred Liabilities is HK$0.0 Mil as of Mar. 2026. GuruFocus rates HKSE:02493 with a GF Score™ of 43/100 and a GF Value™ of HK$95.37 (Possible Value Trap). The stock has 5 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Mabwell (Shanghai) Bioscience Co's non-current deferred liabilities for the quarter that ended in Mar. 2026 was HK$0.0 Mil.

Try GuruFocus Premium free for 7 days

Unlock GF Score, GF Value, 30-Y financials, and pro screeners.

Get Started →

Mabwell (Shanghai) Bioscience Co NonCurrent Deferred Liabilities Related Terms

Mabwell (Shanghai) Bioscience Co NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Mabwell (Shanghai) Bioscience Co's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mabwell (Shanghai) Bioscience Co NonCurrent Deferred Liabilities Chart

Mabwell (Shanghai) Bioscience Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

NonCurrent Deferred Liabilities

Get a 7-Day Free Trial

0.00

Mabwell (Shanghai) Bioscience Co Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
NonCurrent Deferred Liabilities	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

43GF Score

Mabwell (Shanghai) Bioscience Co Ltd HKSE:02493

NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

Frequently Asked Questions Learn more about NonCurrent Deferred Liabilities →

What does a NonCurrent Deferred Liabilities of HK$0.0 Mil mean?

Mabwell (Shanghai) Bioscience Co (HKSE:02493) has a NonCurrent Deferred Liabilities of HK$0.0 Mil as of Mar. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Mabwell (Shanghai) Bioscience Co and its competitors.

Is Mabwell (Shanghai) Bioscience Co's NonCurrent Deferred Liabilities too high?

Mabwell (Shanghai) Bioscience Co's current NonCurrent Deferred Liabilities is HK$0.0 Mil. Overall, Mabwell (Shanghai) Bioscience Co has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Mabwell (Shanghai) Bioscience Co's NonCurrent Deferred Liabilities compare to VRTX and REGN?

Mabwell (Shanghai) Bioscience Co's NonCurrent Deferred Liabilities of HK$0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good NonCurrent Deferred Liabilities for a Biotechnology company?

A good NonCurrent Deferred Liabilities depends on the Biotechnology industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high NonCurrent Deferred Liabilities mean?

A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Mabwell (Shanghai) Bioscience Co and its competitors. Mabwell (Shanghai) Bioscience Co's current NonCurrent Deferred Liabilities is HK$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Mabwell (Shanghai) Bioscience Co stock overvalued right now?

Based on GuruFocus' analysis, Mabwell (Shanghai) Bioscience Co (HKSE:02493) is currently considered Possible Value Trap. The stock's GF Value™ is HK$95.37, compared to a current price of HK$22.50 — trading 76.4% below its estimated fair value. The current NonCurrent Deferred Liabilities is HK$0.0 Mil. Mabwell (Shanghai) Bioscience Co's overall GF Score™ is 43/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is NonCurrent Deferred Liabilities calculated?

NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Mabwell (Shanghai) Bioscience Co (HKSE:02493), the current NonCurrent Deferred Liabilities is HK$0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mabwell (Shanghai) Bioscience Co (HKSE:02493) Overvalued in 2026?

Based on GuruFocus' analysis, Mabwell (Shanghai) Bioscience Co stock appears to be undervalued. The current stock price of HK$22.50 is trading 76.4% below its estimated GF Value™ of HK$95.37. GuruFocus considers Mabwell (Shanghai) Bioscience Co to be Possible Value Trap.

Key valuation signals for HKSE:02493:

NonCurrent Deferred Liabilities: HK$0.0 Mil
GF Value™: HK$95.37 vs. price of HK$22.50 (76.4% below fair value)
GF Score™: 43/100 with 5 warning signs

No single metric tells the full story. See the HKSE:02493 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →